Skip to search.
 TSX Up 0.40% TSX Ventures Down 0.19%

Opexa Therapeutics, Inc. (OPXA)

-NasdaqCM
0.84 Down 0.03(3.89%) 2:57PM EST - Nasdaq Real Time Price
Add to Portfolio
Prev Close:0.88
Open:0.88
Bid:0.84 x 300
Ask:0.85 x 100
1y Target Est:4.00
Beta:2.13
Earnings Date:May 12 - May 18 (Est.)
Day's Range:0.80 - 0.91
52wk Range:0.67 - 2.20
Volume:687,172
Avg Vol (3m):177,570
Market Cap:23.74M
P/E (ttm):N/A
EPS (ttm):-0.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OPXADown 3.89%23.74M
SNYUp 0.12%127.37B
TEVAUp 0.01%48.19B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.51
Quarterly EPS Est (Mar-15) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) based on its proprietary T-cell technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback